Infliximab Versus Vedolizumab in Outpatient Treatment of Immune Checkpoint Inhibitor Colitis

被引：0
|
作者：
Joseph, Joel A. [1 ]
Townsend, Matthew J. [2 ]
Somappa, Aakash K. [1 ]
Sack, Jordan [3 ]
Leboeuf, Nicole R. [4 ]
Sharon, Elad [4 ]
Grover, Shilpa [3 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[4] Harvard Med Sch, Dana Farber Brigham Canc Ctr, Boston, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001029268.66368.a0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S225
引用
收藏
页码：S164 / S165
页数：2
相关论文
共 50 条
  • [31] Immune Checkpoint Inhibitor-Induced Colitis
    Thomas, Anusha S.
    Lu, Yang
    Campbell, Mathew
    Thompson, John A.
    Tan, Dongfeng
    Faleck, David M.
    Wang, Yinghong
    GASTROENTEROLOGY, 2025, 168 (01) : 21 - 28
  • [32] Use of a JAK inhibitor for the treatment of steroid- and infliximab-refractory colitis under immune checkpoint inhibitor therapy with ipilimumab/nivolumab - a case report
    Reiser, S.
    Naoum, C.
    Gauss, A.
    Enk, A.
    Hassel, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 53 - 53
  • [33] Two Cases of Cytomegalovirus Colitis During the Treatment of Immune Checkpoint Inhibitor-Associated Colitis
    Iwamuro, Masaya
    Tanaka, Takehiro
    Makimoto, Go
    Ichihara, Eiki
    Hiraoka, Sakiko
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [34] Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis
    Alexander, James L.
    Ibraheim, Hajir
    Richards, Camellia
    Shum, Ben
    Pavlidis, Polychronis
    Hunter, Nikki
    Teare, Julian P.
    Wotherspoon, Andrew
    Furness, Andrew
    Turajlic, Samra
    Pickering, Lisa
    Larkin, James
    Speight, Ally
    Papa, Sophie
    Powell, Nick
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)
  • [35] A case of gastritis caused by immune checkpoint inhibitor treated with infliximab
    Itsukage, Shizu
    Kume, Noriko
    Tajima, Aki
    Okazaki, Takashi
    Tsuta, Koji
    Tanizaki, Hideaki
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (04): : 454 - 459
  • [36] How Many Doses of Infliximab Should Be Used in Immune Checkpoint Inhibitor-Induced Colitis? - A Retrospective Study
    Kundu, Rupayan
    Chatterjee, Arjun
    Zabor, Emily
    Isaacs, James
    Truong, Thach-Giao
    Sleiman, Joseph
    Funchain, Pauline
    Philpott, Jessica
    Kennedy, Lucy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S812 - S813
  • [37] Immune Checkpoint Inhibitor-Induced Colitis Presenting As Lymphocytic Colitis
    Khan, Jaffar
    Katona, Terrence
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [38] The role of the microbiome in immune checkpoint inhibitor colitis and hepatitis
    Ryan, Thomas
    Ling, Sophia
    Trinh, Andrew
    Segal, Jonathan P.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2024, 72
  • [39] A RARE CASE OF FATAL IMMUNE CHECKPOINT INHIBITOR COLITIS
    Shaukat, Fahd
    Malik, Muhammad Ahmed
    Shanmukhappa, Sanjana Chetana
    Renjithlal, Sarath Lal Mannumbeth
    Ramakrishnan, Sanjana
    Jahshan, Bishara
    CHEST, 2023, 164 (04) : 2784A - 2785A
  • [40] Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis
    Westdorp, Harm
    Sweep, Mark W. D.
    Gorris, Mark A. J.
    Hoentjen, Frank
    Boers-Sonderen, Marye J.
    van der Post, Rachel S.
    van den Heuvel, Michel M.
    Piet, Berber
    Boleij, Annemarie
    Bloemendal, Haiko J.
    de Vries, I. Jolanda M.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345